$ATI

Fields Kimberly A sold $4.6M of ATI

Fields Kimberly A (Chair, President and CEO) sold 25,823 shares of ATI INC (ATI) at $177.97 ($4.60M total) on 2026-06-02 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Fields Kimberly A
Published Jun 4, 2026, 11:14 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 4, 2026, 11:16 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ATI
Neutral
medium confidence
Mentioned
$ATI
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ATINeutralLow
01

Why it matters

Traders may watch for clustering of insider sales/buys or plan changes, but this filing alone is not a fundamental catalyst.

02

Market read

A dated insider sale at a specific price provides modest sentiment/flow information, but 10b5-1 reduces interpretive weight.

03

What to watch

The sale is only one transaction; without follow-on buys/sells or changes in plan parameters, signal quality is low.

Relevance 6/10Novelty 4/10Timing: Filed June 4 for a June 2 insider sale at ~$177.97/share.

Background

SEC Form 4 reports insider transactions; this one is an open-market sale by ATI’s Chair/President/CEO under a Rule 10b5-1 plan.

Company-level read

Ticker impact

$ATINeutralMedium confidence
Context

ATI CEO/Chair Kimberly A. Fields sold 25,823 shares for ~$4.60M via an open-market transaction under a 10b5-1 plan.

Expected impact

Likely limited near-term impact; any reaction is more sentiment/flow-driven than fundamental.

Evidence & confidence

Form 4 provides a dated sale price and size, but it is explicitly under a pre-arranged 10b5-1 plan, reducing interpretive signal.

Market effects

Minimal; this is company-specific insider activity without sector-wide catalyst.

None indicated.

None indicated.

Counterpoint

10b5-1 sales are often routine liquidity events; the disclosure may not reflect bearish expectations.

Key entities

  • ATI INC

    Subject of the Form 4 insider transaction disclosure.

  • Fields Kimberly A

    ATI Chair, President and CEO who sold shares under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ATIMed

How Investors Are Reacting To ATI (ATI) Record Backlog And Raised Guidance

ATI Inc. raised its 2026 adjusted EBITDA and free cash flow guidance, citing record backlog and strong aerospace and defense demand. The company's updated outlook includes high teens defense growth, reinforcing its long-cycle thesis. ATI's share price is up 64% year-to-date, outpacing its industry group. Key risks include execution challenges and softer demand in industrial and medical sectors.

$ATIMed

ATI Shares Surge 64% YTD: What's Driving the Momentum?

ATI Inc. shares have surged 64% year to date, outperforming the aerospace-defense industry and S&P 500. The company reports strong aerospace and defense demand, a record backlog, and improved profitability. Q2 2026 jet-engine revenue rose 13%, defense sales increased 36% to $162M, and adjusted EBITDA grew 37% to $284.4M. ATI raised its 2026 adjusted EBITDA outlook to $1.135-$1.185B and adjusted free cash flow guidance to $550-$600M.

$ATIMed

4 Top Aerospace & Defense Stocks to Consider as America Commemorates 9/11

Four aerospace and defense stocks (ATI, DCO, IA, LOAR) are highlighted as Strong Buys by Zacks, with strong Q2 earnings and raised guidance. ATI reported $1.26B in sales (+10% YoY), record backlog of $4.4B, and raised 2026 EPS guidance. DCO saw record revenue of $224.5M (+11% YoY) and adjusted EPS of $1.18 (+34% YoY). IA reported $26.7M in sales (+11% YoY) and doubled adjusted EPS to $0.33. LOAR posted $171.6M in sales (+39% YoY) and raised 2026 EPS outlook.

$ATIMed

Extended Strategic Agreements to Support Management’s Full-Year 2026 Guidance Raise for ATI Inc. (ATI)

ATI Inc. (NYSE:ATI) raised its 2026 guidance after Q2 revenue rose 11% YoY to $1.26B, with adjusted EBITDA at $284.4M. The company secured long-term supply deals with BWX Technologies and Boeing, supporting its bullish outlook. However, risks include customer concentration and raw material cost volatility. Analysts remain bullish, with a consensus target price of $255.

$ATIMedAI 9/10

ATI’s (ATI) Record Backlog And Raised Guidance Signal Bigger Ambitions

ATI Inc. (NYSE:ATI) reported Q2 sales of $1.26B, up 11% YoY, with net income rising 50% to $151M. The company raised its full-year 2026 outlook, citing strong demand in aerospace and defense. ATI's backlog reached a record $4.4B, up 18% YoY. CEO Kimberly Fields noted demand outpacing supply, and the company repurchased $50M in shares. However, margins in one segment slipped, and debt increased to fund growth.

$ATIMed

Here's How Much a $1000 Investment in ATI Made 10 Years Ago Would Be Worth Today

ATI Inc., a Pittsburgh-based specialty materials producer, restructured in 2013 and 2020, focusing on High-Performance Materials & Components and Advanced Alloys & Solutions. In Q1 2026, earnings beat estimates but revenues missed. The company benefits from aerospace and defense demand but faces risks from production ramps and supply-chain issues.